385 related articles for article (PubMed ID: 27736657)
1. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
Brigo F; Bragazzi N; Nardone R; Trinka E
Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
[TBL] [Abstract][Full Text] [Related]
2. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
Misra UK; Kalita J
Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
[TBL] [Abstract][Full Text] [Related]
3. A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus.
Brigo F; Igwe SC; Nardone R; Tezzon F; Bongiovanni LG; Trinka E
Epileptic Disord; 2013 Sep; 15(3):314-23. PubMed ID: 23981687
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of intravenous levetiracetam in status epilepticus: A meta-analysis and systematic review.
Chu SS; Wang HJ; Zhu LN; Xu D; Wang XP; Liu L
Seizure; 2020 Jan; 74():49-55. PubMed ID: 31830677
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam versus phenytoin in management of status epilepticus.
Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
[TBL] [Abstract][Full Text] [Related]
6. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD
J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Angurana SK; Suthar R
J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.
DeMott JM; Slocum GW; Gottlieb M; Peksa GD
Epilepsy Behav; 2020 Oct; 111():107286. PubMed ID: 32707535
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
Sánchez Fernández I; Gaínza-Lein M; Lamb N; Loddenkemper T
Neurology; 2019 May; 92(20):e2339-e2348. PubMed ID: 31068480
[TBL] [Abstract][Full Text] [Related]
10. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
Alvarez V; Januel JM; Burnand B; Rossetti AO
Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
[TBL] [Abstract][Full Text] [Related]
11. IV Valproate in generalized convulsive status epilepticus: a systematic review.
Brigo F; Storti M; Del Felice A; Fiaschi A; Bongiovanni LG
Eur J Neurol; 2012 Sep; 19(9):1180-91. PubMed ID: 22182304
[TBL] [Abstract][Full Text] [Related]
12. Intravenous sodium valproate in status epilepticus: review and Meta-analysis.
Liampas I; Siokas V; Brotis A; Zintzaras E; Stefanidis I; Dardiotis E
Int J Neurosci; 2021 Jan; 131(1):70-84. PubMed ID: 32075481
[No Abstract] [Full Text] [Related]
13. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis.
Yi ZM; Zhong XL; Wang ML; Zhang Y; Zhai SD
Front Pharmacol; 2020; 11():751. PubMed ID: 32670054
[TBL] [Abstract][Full Text] [Related]
15. A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus.
Brigo F; Bragazzi NL; Lattanzi S; Nardone R; Trinka E
Eur J Neurol; 2018 Mar; 25(3):451-463. PubMed ID: 29288520
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
[TBL] [Abstract][Full Text] [Related]
17. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis.
Brigo F; Del Giovane C; Nardone R; Trinka E; Lattanzi S
Epilepsy Behav; 2019 Dec; 101(Pt B):106466. PubMed ID: 31462385
[TBL] [Abstract][Full Text] [Related]
18. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA
Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus.
Liu X; Wu Y; Chen Z; Ma M; Su L
Int J Neurosci; 2012 Jun; 122(6):277-83. PubMed ID: 22248033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
